ADVFN US – Market Content Editor
-

Pony AI shares climb after earnings beat and strong robotaxi growth
Pony AI Inc. (NASDAQ:PONY) reported fourth-quarter results on Thursday that topped analyst forecasts, posting adjusted earnings per share of $0.12 and revenue of $29.1 million. The company also unveiled a strategic agreement to introduce what it described as the first commercial robotaxi service in Europe, with operations set to begin soon in Zagreb. Shares of…
-

Clarivate publishes AI50 list highlighting leading AI innovators
Clarivate Plc (NYSE:CLVT) has introduced its AI50 benchmark, a ranking that highlights 50 organizations recognized for their leadership in artificial intelligence innovation based on an analysis of global patent data. The list features major technology companies including NVIDIA, Micron Technology, Alphabet, Qualcomm and Foxconn. Clarivate noted that more than half of the organizations included in…
-

Accenture unveils Cyber.AI platform built on Anthropic’s Claude model
Accenture (NYSE:ACN) has introduced Cyber.AI, a new cybersecurity platform powered by Anthropic’s Claude artificial intelligence model, the company said in a press release. The tool is designed to help organizations shift from traditional human-paced responses to always-on, AI-driven security operations. Cyber.AI integrates Accenture’s proprietary library of autonomous agents with the reasoning capabilities of Claude. Within…
-

Gold retreats as investors weigh mixed signals on U.S.-Iran de-escalation
Gold prices declined during Asian trading on Thursday as markets assessed conflicting developments surrounding the Iran conflict, while a stronger U.S. dollar reduced the appeal of bullion. By 03:00 ET (07:00 GMT), spot gold had fallen 1.1% to $4,457.06 an ounce. U.S. gold futures dropped 2.2% to $4,485.10. The precious metal had recovered earlier in…
-

Oil rises as Iran weighs U.S. proposal aimed at ending conflict
Oil prices moved higher on Thursday as markets reacted to mixed signals about possible de-escalation in the Middle East, while Iran considered a U.S. proposal intended to bring the war to an end. By 05:33 ET (09:33 GMT), Brent crude futures for May delivery, the global benchmark, had gained 4.0% to $106.34 per barrel. U.S.…
-

Futures slip while oil holds above $100 as markets track Iran conflict developments: Dow Jones, S&P, Nasdaq, Wall Street
U.S. equity futures pointed lower on Thursday as investors sifted through a wave of reports about possible negotiations aimed at ending the Iran conflict. Oil prices remained above $100 per barrel, the U.S. dollar strengthened slightly and gold prices moved lower. Meanwhile, Jefferies Financial (NYSE:JEF) reported first-quarter results that were weighed down by losses tied…
-

Markets in Motion: gold sentiment hits extremes as energy sets up
Key Takeaways Gold weakness may be signalling a turning point Markets remain volatile as geopolitical tensions continue to drive sharp moves across commodities, particularly gold and silver. In this week’s Markets in Motion, Bruce Campbell highlights a notable shift in gold sentiment, with multiple indicators approaching levels that have historically aligned with market bottoms. Data…
-

Middle East Peace Hopes and Falling Oil Prices Lift Wall Street
U.S. stocks closed broadly higher on Wednesday as investors embraced reports that the White House had delivered a comprehensive 15-point ceasefire proposal to Iran, raising hopes for a diplomatic resolution to the conflict that has rattled markets throughout March. Falling crude oil prices added fuel to the rally, easing the inflation concerns that weighed on…
-

Corcept shares soar after FDA approves relacorilant cancer treatment
Shares of Corcept Therapeutics (NASDAQ:CORT) surged about 40% on Wednesday after the U.S. Food and Drug Administration (FDA) approved relacorilant (Lifyorli) in combination with nab-paclitaxel for the treatment of adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. The approval covers patients who have previously undergone one to three systemic treatment regimens, including…
-

Chewy shares jump after strong fourth-quarter earnings beat
Shares of Chewy Inc. (NYSE:CHWY) climbed about 10% in premarket trading after the online pet retailer reported fourth-quarter results that topped analyst expectations. The company posted adjusted earnings per share of $0.27, exceeding the analyst consensus of $0.09 by $0.18. Quarterly revenue totaled $3.26 billion, in line with forecasts and marking 8.1% growth on a…